Hochman David P

USNatural personDirector

Transactions

157

Issuers

Buys / Sells

48/0

Last tx

15 May 2026

Behaviour

2 purchases reported after at least 12 months of silence — most recent on 04 Dec 2020.

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
SEARCH BY HEADLINES.COM CORP.	1,200,000	reported	13 Mar 2017	tx 28+59,291,274−1,857,103.99
Orchestra BioMed Holdings, Inc.	1,059,029	reported	15 May 2026	tx 63+3,792,134−287,463
IMMUNE RESPONSE CORP	570,875	reported	30 Mar 2007	tx 11+111,497,500−465,350
Motus GI Holdings, Inc.	50,000	reported	10 Feb 2022	tx 33+2,981,564

Track record

Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 13 buys in history.

1 month

+14.5%

Sample13

Win rate (≥5%)77%

Hit rate (>0)85%

3 months

+9.1%

Sample13

Win rate (≥5%)62%

Hit rate (>0)62%

6 months

+13.6%

Sample12

Recent transactions

Date	Type	Issuer	Qty	Price
15 May 2026	PURCHASE	Orchestra BioMed Holdings, Inc.	5,000	3.77 USD
25 Mar 2026	TAX_WITHHOLDING	Orchestra BioMed Holdings, Inc.	32,438	4.57 USD
13 Mar 2026	PURCHASE	Orchestra BioMed Holdings, Inc.	10,000	4.29 USD
12 Feb 2026	GRANT_AWARD	Orchestra BioMed Holdings, Inc.	504,000	0.00 USD
10 Dec 2025	TAX_WITHHOLDING	Orchestra BioMed Holdings, Inc.	40,355

InsiderLens aggregates public information issued by financial regulators (SEC, AMF, FCA, BaFin, AFM, FI, HKEX, ASX). The service constitutes neither investment advice nor a recommendation to buy or sell. Past performance is no guarantee of future results. Investing in financial instruments carries the risk of capital loss.

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
SEARCH BY HEADLINES.COM CORP.	1,200,000	reported	13 Mar 2017	tx 28+59,291,274−1,857,103.99
Orchestra BioMed Holdings, Inc.	1,059,029	reported	15 May 2026	tx 63+3,792,134−287,463
IMMUNE RESPONSE CORP	570,875	reported	30 Mar 2007	tx 11+111,497,500−465,350
Motus GI Holdings, Inc.	50,000	reported	10 Feb 2022	tx 33+2,981,564

Track record

Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 13 buys in history.

1 month

+14.5%

Sample13

Win rate (≥5%)77%

Hit rate (>0)85%

3 months

+9.1%

Sample13

Win rate (≥5%)62%

Hit rate (>0)62%

6 months

+13.6%

Sample12

Recent transactions

Date	Type	Issuer	Qty	Price
15 May 2026	PURCHASE	Orchestra BioMed Holdings, Inc.	5,000	3.77 USD
25 Mar 2026	TAX_WITHHOLDING	Orchestra BioMed Holdings, Inc.	32,438	4.57 USD
13 Mar 2026	PURCHASE	Orchestra BioMed Holdings, Inc.	10,000	4.29 USD
12 Feb 2026	GRANT_AWARD	Orchestra BioMed Holdings, Inc.	504,000	0.00 USD
10 Dec 2025	TAX_WITHHOLDING	Orchestra BioMed Holdings, Inc.	40,355